ticlopidine - oral, Ticlid
GENERIC NAME: TICLOPIDINE - ORAL (tie-KLO-pih-deen)
BRAND NAME(S): Ticlid
WARNING: Rarely, this medication has caused serious, sometimes life-threatening blood and immune disorders (agranulocytosis, aplastic anemia, neutropenia, thrombotic thrombocytopenic purpura-TTP). Symptoms may appear within the first few days after starting this medication. Seek immediate attention if you notice any of these rare but serious side effects: difficulty speaking, weakness on one side of the body, seizures, red pinpoint-sized bleeding spots on the skin, dark-colored urine, or yellowing of eyes/skin (see also Side Effects section).
Your doctor will be monitoring your blood counts before and regularly during treatment, especially the first 3 months of therapy. It is important that you keep all your medical and laboratory appointments.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index
- Allergic Skin Disorders
- Bacterial Skin Diseases
- Bites and Infestations
- Diseases of Pigment
- Fungal Skin Diseases
- Medical Anatomy and Illustrations
- Noncancerous, Precancerous & Cancerous Tumors
- Oral Health Conditions
- Papules, Scales, Plaques and Eruptions
- Scalp, Hair and Nails
- Sexually Transmitted Diseases (STDs)
- Vascular, Lymphatic and Systemic Conditions
- Viral Skin Diseases
- Additional Skin Conditions